We assess that menopausal women are menopausal before treating them with HRT, however. So your analogy only works if we have a menopause-reliability method of determining trans status.

The problem with Chu's position comes from the illogic of "someone has used this reasoning fallaciously to restrict care" to conclude (or imply) "therefore this entire area is to be ignored".